Cerebral Palsy and Epilepsy in Children: Clinical Perspectives on a Common Comorbidity
Piero Pavone1, Carmela Gulizia2, Alice Le Pira1
1Unit of Clinical Pediatrics, Department of Clinical and Experimental Medicine, AOU "Policlinico", PO "G. Rodolico", University of Catania, 95123 Catania, Italy.
Insights
Epilepsy is a common comorbidity in children with cerebral palsy (CP), particularly those with severe motor impairments. Early identification and treatment of epilepsy in CP patients are crucial for better outcomes.
Area of Science:
- Pediatric Neurology
- Childhood Disability Studies
- Epileptology
Background:
- Cerebral palsy (CP) is a leading cause of childhood disability.
- Epilepsy affects approximately 40% of children with CP, representing a significant comorbidity.
- Understanding the relationship between CP types and epilepsy is crucial for patient management.
Purpose of the Study:
- To analyze clinical aspects of different cerebral palsy (CP) types.
- To investigate the relationship between clinical data and CP types in children with comorbid epilepsy.
- To report on the experience of analyzing CP and epilepsy comorbidities.
Main Methods:
- Retrospective, single-center study involving 93 children with CP.
- Classification of CP based on motor presentation (spastic quadriplegia, hemiplegia, diplegia, etc.).
- Comparison of children with CP and epilepsy (n=46) against a control group of children with epilepsy without other neurological disorders (n=136).
Main Results:
- Spastic hemiplegia was the most common CP type (42%) among the studied CP cohort.
- Epilepsy frequency was higher in CP children with severe motor dysfunction (GMFCS IV-V).
- Children with CP and epilepsy had a significantly earlier age of epilepsy onset (21 months) compared to controls (67 months).
Conclusions:
- Epilepsy is a highly prevalent comorbidity in cerebral palsy.
- Children with CP, especially those with major motor dysfunction, require careful monitoring for epilepsy.
- Early detection and management of epilepsy in children with CP are essential.
Abstract:
Cerebral palsy (CP) is a frequent cause of childhood disability often associated with a complex group of disorders, including epilepsy, which is reported to impact approximately 40% of affected individuals. This retrospective study involved a group of children affected by CP, some of whom also had comorbid epilepsy. The aim of this study was to report our experience of analyzing, in particular, (a) some of the clinical aspects of the different type of CP, and (b) the relationship between the clinical data of children affected by CP plus epilepsy and each type of CP.
Methods:
This retrospective single-center study was performed with 93 children admitted to the Pediatric Department of the University of Catania, Italy, affected by CP and distinguished according to the type of motor clinical presentation, with 46 showing epileptic seizures, compared to a control group of 136 children affected by epilepsy without other neurologic disorders.
Results:
Among the 93 CP children, 25 (27%) had spastic quadriplegia (plus one patient with dystonic quadriplegia), 39 (42%) had spastic hemiplegia, 11 (12%) had spastic diplegia (plus two with ataxia and one with dyskinetic CP), and 14 (15%) did not have a well-defined type of CP. The frequency of epilepsy was higher in affected CP children who showed major motor dysfunction (GMFCS IV-V types). As regards the 46 children with CP plus epilepsy, compared to the group of the control, the age of epilepsy onset was found to be statistically significant: 21 ± 35.1 months vs. 67 ± 39.7.
Conclusions:
Epilepsy represents one of the most frequent comorbidities of cerebral palsy. In children with CP, particular attention should be paid to the early identification and treatment of comorbid epilepsy.
More Related Videos
09:57Author Spotlight: Advancing Pediatric Epilepsy Surgery in Children Through Novel Biomarkers and Enhanced Localization
Published on: September 20, 2024
06:04Author Spotlight: Studying Clinical Characters and Epilepsy Outcomes After Frontal Disconnection in Patients with MOGHE
Published on: August 16, 2024
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Seizures: Classification
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Language and Cognition
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Glutamate Antagonists
